Alkeon Capital Management - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 79 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$21,049,699
-9.0%
3,479,289
+16.8%
0.04%
-5.0%
Q2 2023$23,119,283
+69.1%
2,979,289
+24.2%
0.04%
+33.3%
Q1 2023$13,675,737
-3.2%
2,399,2520.0%0.03%
-45.5%
Q4 2022$14,131,594
+109.6%
2,399,252
+13.9%
0.06%
+150.0%
Q3 2022$6,742,000
-28.6%
2,106,9680.0%0.02%
-12.0%
Q2 2022$9,439,000
-7.3%
2,106,968
+10.5%
0.02%
+25.0%
Q1 2022$10,183,000
-51.5%
1,906,968
+33.6%
0.02%
-48.7%
Q4 2021$20,977,000
+0.6%
1,426,968
+43.1%
0.04%
+11.4%
Q3 2021$20,847,000
+18.2%
996,9890.0%0.04%
+34.6%
Q2 2021$17,637,000
-27.9%
996,989
-0.1%
0.03%
-27.8%
Q1 2021$24,452,000
-19.6%
998,061
+11.1%
0.04%
-26.5%
Q4 2020$30,399,000
+301.1%
898,061
+196.3%
0.05%
+250.0%
Q3 2020$7,579,000303,0610.01%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Column Group LLC 4,768,181$84,349,00011.94%
Memorial Sloan Kettering Cancer Center 602,272$10,654,0006.96%
Euclidean Capital LLC 996,734$17,632,0005.72%
Invus Financial Advisors, LLC 1,007,575$17,824,0003.55%
EcoR1 Capital, LLC 3,092,218$54,701,0002.04%
Orbimed Advisors 2,337,574$41,352,0000.42%
EMERALD ADVISERS, LLC 602,758$10,663,0000.39%
EMERALD MUTUAL FUND ADVISERS TRUST 557,210$9,857,0000.32%
Casdin Capital, LLC 601,515$10,641,0000.27%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 53,000$938,0000.25%
View complete list of ORIC PHARMACEUTICALS INC shareholders